Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 262,640 shares at $6.28 ($1.6M) on 2025-10-27, disclosed to the SEC on 2025-10-29.
Open-market purchase of $1.6M NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.06 | 46,900 | $284K | 17.4% |
| 2 | $6.15 | 35,034 | $215K | 13.2% |
| 3 | $6.15 | 35,034 | $215K | 13.2% |
| 4 | $6.28 | 72,836 | $457K | 28.1% |
| 5 | $6.28 | 72,836 | $457K | 28.1% |
| Total | $6.21 avg | 262,640 |
| $1.6M |
| 100% |
| Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |
| NVCT | BUY | 2025-05-12 | $423K | — | Filing → |